High levels of resistance to nucleoside/nucleotide reverse transcriptase inhibitors in newly diagnosed antiretroviral treatment-naive children in sub-Saharan Africa

Seth C. Inzaule, Michael R. Jordan, George Bello, Nellie Wadonda-Kabondo, Salou Mounerou, Innocent A. Mbulli, Sulaimon A. Akanmu, Adolfo Vubil, Gillian Hunt, Pontiano Kaleebu, Simangele Mthethwa-Hleza, Janet Dzangare, Patrick Njukeng, Martina Penazzato, Tobias F. Rinke De Wit, Susan H. Eshleman, Silvia Bertagnolio

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

Exposure of infants to antiretroviral drugs for prevention of mother-to-child transmission can induce resistance to nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs). Data from nine national surveys of pretreatment drug resistance in children newly diagnosed with HIV show high levels of resistance to NRTIs included in first-line antiretroviral treatment (ART) regimens (dual abacavir-lamivudine/emtricitabine resistance). Additional research is needed to determine the impact of NRTI resistance on treatment response and optimize infant ART.

Original languageEnglish (US)
Pages (from-to)1567-1570
Number of pages4
JournalAIDS
Volume34
Issue number10
DOIs
StatePublished - Aug 1 2020

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Infectious Diseases

Fingerprint

Dive into the research topics of 'High levels of resistance to nucleoside/nucleotide reverse transcriptase inhibitors in newly diagnosed antiretroviral treatment-naive children in sub-Saharan Africa'. Together they form a unique fingerprint.

Cite this